Finance

Lists
Outlook: 36.8% bullish·0.0% bearish
Go to analysis
CVS:NYSE
CVS Health Corp
US$86,13
-0,98%
(-0,86) 1D
6 ຕ.ລ., 15 ໂມງ 45 ນາທີ 37 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CVS...
Open
US$86,80
High
US$87,08
Low
US$85,52
Mkt. cap
109,46 ຕື້
Avg. vol.
7,61 ລ້ານ
Volume
5,88 ລ້ານ
Dividend
3,09%
Quarterly dividend
US$0,67
Ex-dividend date
23 ມ.ສ. 2026
P/E ratio
22,84
52-wk high
US$110,68
52-wk low
US$69,51
EPS
US$3,77
Beta
0,60
Shares outstanding
1,28 ຕື້
No. of employees
260 ພັນ
Open
US$86,80
High
US$87,08
Low
US$85,52
Mkt. cap
109,46 ຕື້
Avg. vol.
7,61 ລ້ານ
Volume
5,88 ລ້ານ
Dividend
3,09%
Quarterly dividend
US$0,67
Ex-dividend date
23 ມ.ສ. 2026
P/E ratio
22,84
52-wk high
US$110,68
52-wk low
US$69,51
EPS
US$3,77
Beta
0,60
Shares outstanding
1,28 ຕື້
No. of employees
260 ພັນ
News stories
From web sources and news partners
Profile
CVS Health Corporation is an American multinational healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands. The company is the world's second largest healthcare company, behind UnitedHealth Group. In 2023, the company was ranked 64th in the Forbes Global 2000. CVS started in Lowell, Massachusetts by brothers Stanley and Sidney Goldstein and their partner Ralph Hoagland. The name stood for Consumer Value Stores. Wikipedia
About CVS Health Corp
CEODavid Joyner
Employees260 ພັນ
Founded1963
HeadquartersWoonsocket, ໂຣດ ໄອແລນ, ສະຫະລັດ
SectorHealth care provider
Analyst ratings
Based on 18 analysts giving stock ratings to CVS in the past 3 months
Strong buy
Buy
18
Hold
0
Sell
0
12-month forecast
Based on 18 Wall Street analysts offering 12 month price targets for CVS in the last 3 months.
Highest
Current US$86,13
US$125,00 (+45,13%)
Average
US$114,78 (+33,26%)
Lowest
US$107,00 (+24,23%)
Analyst
Recommendation
Action
Price target
Projected
Date
Allen Lutz
Bank of America Securities
Buy
Reiterated
US$110,00
+27,7%
10/06/2026
Lance Wilkes
Bernstein
Buy
Maintained
US$112,00
+30%
10/05/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
US$125,00
+45,1%
10/02/2026
Stephen Baxter
Wells Fargo
Buy
Maintained
US$123,00
+42,8%
09/15/2026
Kevin Caliendo
UBS
Buy
Reiterated
US$118,00
+37%
09/03/2026
Brian Tanquilut
Jefferies
Buy
Maintained
US$120,00
+39,3%
08/31/2026
Charles Rhyee
TD Cowen
Buy
Maintained
US$110,00
+27,7%
08/26/2026
Jessica Tassan
Piper Sandler
Buy
Maintained
US$113,00
+31,2%
08/26/2026
Steven Silver
Argus Research
Buy
Maintained
US$114,00
+32,4%
08/18/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
US$118,00
+37%
08/12/2026
Erin Wright
Morgan Stanley
Buy
Reiterated
US$111,00
+28,9%
08/10/2026
Ben Hendrix
RBC Capital
Buy
Maintained
US$113,00
+31,2%
08/06/2026
Michael Ha
Robert W. Baird
Buy
Maintained
US$107,00
+24,2%
08/06/2026
David S Macdonald
Truist Financial
Buy
Reiterated
US$118,00
+37%
08/06/2026
Andrew Mok CFA
Barclays
Buy
Maintained
US$108,00
+25,4%
08/06/2026
Scott Fidel
Goldman Sachs
Buy
Maintained
US$116,00
+34,7%
07/27/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
US$120,00
+39,3%
07/13/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
US$110,00
+27,7%
07/07/2026
Rajesh Kumar
HSBC
Hold
Maintained
US$103,00
+19,6%
07/06/2026
George Hill
Deutsche Bank
Buy
Maintained
US$92,00
+6,8%
05/07/2026
Courtney Breen
Bernstein
Buy
Maintained
US$94,00
+9,1%
03/30/2026
Michael Cherny
Leerink Partners
Buy
Reiterated
US$98,00
+13,8%
03/24/2026
Unknown Analyst
Oppenheimer
Hold
Reiterated
-
-
02/11/2026
Last report
5 ສ.ຫ. 2026
Fiscal period
Q2 2026
US$2,58 / US$1,85
+39,36%beat
Revenue / Est. (USD)
105,46 ຕື້ / 100,09 ຕື້
+5,36%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
102,24 ຕື້
105,10 ຕື້
99,85 ຕື້
105,46 ຕື້
Cost of goods sold
89,06 ຕື້
92,13 ຕື້
84,80 ຕື້
90,35 ຕື້
Cost of revenue
89,06 ຕື້
92,13 ຕື້
84,80 ຕື້
90,35 ຕື້
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,86 ຕື້
11,32 ຕື້
10,93 ຕື້
11,04 ຕື້
Operating expense
10,86 ຕື້
11,32 ຕື້
10,93 ຕື້
11,04 ຕື້
Total operating expenses
99,92 ຕື້
103,45 ຕື້
95,73 ຕື້
101,38 ຕື້
Operating income
2,32 ຕື້
1,65 ຕື້
4,12 ຕື້
4,07 ຕື້
Other non operating income
26,00 ລ້ານ
-88,00 ລ້ານ
32,00 ລ້ານ
31,00 ລ້ານ
EBT including unusual items
-3,48 ຕື້
1,35 ຕື້
3,94 ຕື້
3,98 ຕື້
EBT excluding unusual items
2,19 ຕື້
1,37 ຕື້
3,95 ຕື້
3,99 ຕື້
Income tax expense
508,00 ລ້ານ
-1,57 ຕື້
981,00 ລ້ານ
982,00 ລ້ານ
Effective tax rate
-14,59%
-115,88%
24,91%
24,69%
Other operating expenses
-
-
-
-
Net income
-3,98 ຕື້
2,94 ຕື້
2,94 ຕື້
2,98 ຕື້
Net profit margin
-3,89%
2,80%
2,95%
2,82%
Earnings per share
1,60
1,09
2,57
2,58
Interest and investment income
632,00 ລ້ານ
594,00 ລ້ານ
574,00 ລ້ານ
641,00 ລ້ານ
Interest expense
-784,00 ລ້ານ
-787,00 ລ້ານ
-774,00 ລ້ານ
-757,00 ລ້ານ
Net interest expenses
-152,00 ລ້ານ
-193,00 ລ້ານ
-200,00 ລ້ານ
-116,00 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
3,45 ຕື້
2,80 ຕື້
5,23 ຕື້
5,20 ຕື້
Gain or loss from assets sale
-483,00 ລ້ານ
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google